New hope for ALS: major trial tests drug to slow devastating nerve disease
NCT ID NCT07325591
Summary
This study is testing an oral medication called tazbentetol to see if it can slow the progression of ALS and help people maintain their daily abilities. About 430 adults with ALS will be randomly assigned to receive either the study drug or a placebo for 36 weeks, followed by an optional extension period. The main goal is to measure changes in physical function, safety, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.